Genelux (GNLX) Research & Development (2022 - 2026)

Genelux has reported Research & Development for 5 years, with the latest figure at $5.8 million in Q1 2026.

• On a quarterly basis, Research & Development rose 22.99% year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $20.9 million, a 6.32% increase from a year earlier, with the FY2025 full-year figure at $19.9 million, up 4.49% from the prior year.
• Research & Development was $5.8 million for Q1 2026 at Genelux, up from $5.7 million in the prior quarter.
• The five-year high for Research & Development was $6.5 million in Q4 2024, with the low at $2.4 million in Q3 2022.
• Average Research & Development over 5 years is $4.2 million, with a median of $4.2 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Research & Development soared 68.56% in 2023, then decreased 13.28% in 2025.
• Over 5 years, Research & Development stood at $2.5 million in 2022, then jumped by 68.56% to $4.2 million in 2023, then jumped by 56.73% to $6.5 million in 2024, then fell by 13.28% to $5.7 million in 2025, then advanced by 2.19% to $5.8 million in 2026.
• The last three Research & Development figures came in at $5.8 million (Q1 2026), $5.7 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.